Intron-2 conversion polymorphism of the aldosterone synthase gene and the antihypertensive response to angiotensin-converting enzyme inhibitors

Journal of Hypertension
Huimin YuGuozhang Liu

Abstract

Aldosterone controls sodium balance and intravascular volume, and thus helps regulate blood pressure. Secretion of aldosterone is mainly regulated at the level of expression of the aldosterone synthase (CYP11B2) gene. The intron-2 conversion polymorphism of CYP11B2 was suggested to lead to overexpression of the gene, and may therefore have potential to predict the blood pressure response of patients with essential hypertension to angiotensin-converting enzyme inhibitors (ACEIs). To investigate the association between the intron-2 conversion polymorphism and the blood pressure response to ACEIs in a hypertensive cohort. After a 2-week, single-blind, placebo run-in period, ACEIs were administered for 6 weeks to 509 patients with mild-to-moderate essential hypertension. The intron-2 conversion polymorphism was examined by polymerase chain reaction. The IwIw genotype was observed in 106 patients (20.8%), the IwIc genotype in 251 patients (49.3%), and the IcIc genotype in 152 patients (29.9%). After 6 weeks of treatment the reductions in diastolic blood pressure were significantly greater in patients carrying IcIc or IwIc compared with IwIw genotypes (9.2 +/- 7.2 or 9.2 +/- 7.1 versus 6.4 +/- 6.6 mmHg, respectively; analysis of vari...Continue Reading

References

Feb 1, 1995·Endocrine Research·P C White, L Slutsker
Jul 28, 1994·The New England Journal of Medicine·P C White
Feb 4, 1999·Hypertension·S TamakiM Kinoshita
Mar 18, 2000·Hypertension·P MulateroF Veglio
Jun 18, 2002·European Journal of Pharmacology·Jan R OrtleppRainer Hoffmann
Sep 6, 2002·The Journal of Clinical Endocrinology and Metabolism·Pitt O LimJohn M C Connell
Mar 12, 2003·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Masahiro KikuyaMitsunobu Matsubara
Jun 6, 2003·The Journal of Clinical Endocrinology and Metabolism·Jérôme NicodPaolo Ferrari
Jun 14, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Amar Akhtar SethiAnne Tybjaerg-Hansen
Apr 2, 2004·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Mitsunobu MatsubaraYutaka Imai
Jan 12, 2005·Journal of Hypertension·Charu RajputM A Qadar Pasha
Jun 13, 2006·Clinical Pharmacology and Therapeutics·Hui-Min YuChun-Yu Deng

❮ Previous
Next ❯

Citations

Dec 22, 2012·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Patricia C Ruiz-PalaciosGilberto Vargas-Alarcón
Jan 28, 2009·Therapeutic Advances in Cardiovascular Disease·Geneviève Escher
Apr 25, 2009·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.